Treatment of tinea capitis with itraconazole

Journal of the American Academy of Dermatology

Volumn 35, Issue 4, 1996, Pages 637-638

  Greer, Donald L ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; GRISEOFULVIN; ITRACONAZOLE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MALE; MYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

EID: 0030453718     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90697-0     Document Type: Article

References (9)

1. Silverman RA. Pediatric mycoses. In: Elewski B, editor. Cutaneous fungal infections. New York: Igaku-Shoin, 1992: 212-28.
2. Gan VN, Petruska M, Ginsburg CM. Epidemiology and treatment of tinea capitis: ketoconazole vs griseofulvin. Pediatr Infect Dis J 1987;6:46-9.
3. Tanz RR, Hebert AA, Esterly NB. Treating tinea capitis: Should ketoconazole replace griseofulvin? J Pediatr 1988; 112:987-91.
4. Elewski BE. Tinea capitis: itraconazole in Trichophyton tonsurans infection. J Am Acad Dermatol 1994;31:65-7.
5. Lukacs A, Korting HC, Lindner A. Successful treatment of griseofulvin-resistant tinea capitis in infants. Mycoses 1994; 37:451-3.
6. Legendre R, Esola-Macre J. Itraconazole in the treatment of tinea capitis. J Am Acad Dermatol 1990;23(suppl):559-60.
7. Habif F. Clinical dermatology. 2nd ed. St Louis: CV Mosby, 1990:318-22.
8. Rippon JW, editor. The pathogenic fungi and pathogenic actinomytes. 3rd ed. Philadelphia: WB Saunders, 1988:186-96.
9. Williams DI, Marten RH. Oral treatment of ringworm with griseofulvin. Lancet 1958;2:1212-3.